Stockreport

Lucira's at Home Molecular Tests Can Detect Omicron (B.1.1.529) SARS CoV-2 Variant of Concern

Lucira Health, Inc.  (LHDX) 
PDF Lucira assessment confirms COVID-19 Check-It (OTC) and All-In-One (Rx) molecular self-test kits' ability to detect 100% of Omicron variant genome sequences analyzedLucir [Read more]